Prognostic Significance of Basic Laboratory Methods in Non-Small-Cell-Lung Cancer |
Kaya, Vildan
(Department of Radiation Oncology, Suleyman Demirel University School of Medicine)
Yildirim, Mustafa (Department of Medical Oncology, Ministry of Health Batman Regional Government Hospital) Demirpence, Ozlem (Department of Biochemistry, Ministry of Health Batman Regional Government Hospital) Yildiz, Mustafa (Department of Medical Oncology, Antalya Education and Research Hospital) Yalcin, Aysen Yesim (Department of Radiation Oncology, Suleyman Demirel University School of Medicine) |
1 | Arrieta O, Michel Ortega RM, Villanueva-Rodriguez G, et al (2010). Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer, 10, 50. DOI ScienceOn |
2 | Ademuyiwa FO, Johnson CS, White AS, et al (2007). Prognostic factors in stage III non-small-cell lung cancer. Clin Lung Cancer, 8, 478-82. DOI ScienceOn |
3 | Bagan P, Berna P, De Dominicis F, et al (2013). Nutritional status and postoperative outcome after pneumonectomy for lung cancer. Ann Thorac Surg, 95, 392-6. DOI ScienceOn |
4 | Bashir Y, Graham TR, Torrance A, et al (1990). Nutritional state of patients with lung cancer undergoing thoracotomy. Thorax, 45, 183-6. DOI |
5 | Caro JJ, Salas M, Ward A, Goss G (2001). Anaemia is an independent prognostic factor for survival in patients with cancer. Cancer, 91, 2214-21. DOI |
6 | Carruthers R, Tho LM, Brown J, et al (2012). Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer. Colorectal Dis, 14, 701-7. DOI ScienceOn |
7 | Cedres S, Torrejon D, Martinez A, et al (2012). Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin Transl Oncol, 14, 864-9. DOI ScienceOn |
8 | Kulesza P, Ramchandran K, Patel JD (2011). Emerging concepts in the pathology and molecular biology of advanced nonsmall cell lung cancer. Am J Clin Pathol, 136, 228-38. DOI ScienceOn |
9 | Kawai H, Ota H (2012). Low perioperative serum prealbumin predicts early recurrence after curative pulmonary resection for non-small-cell lung cancer. World J Surg, 36, 2853-7. DOI ScienceOn |
10 | Keizman D, Ish-Shalom M, Huang P, et al (2012). The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma. Eur J Cancer, 48, 202-8. DOI ScienceOn |
11 | Koukourakis MI, Giatromanolaki A, Sivridis E, et al (2003). Lactate dehydrogenase-5 (LDH-5) overexpression in nonsmall- cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br J Cancer, 89, 877-85. DOI ScienceOn |
12 | Littlewood TJ, Bajetta E, Nortier JW, et al (2001). Epoetin Alfa Study Group. Effects of epoetin alfa on haematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, doubleblind, placebo-controlled trial. J Clin Oncol, 19, 2865-74. DOI |
13 | Sanchez-Lara K, Turcott JG, Juarez E, et al (2012). Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study. Nutr Cancer, 64, 526-34. DOI ScienceOn |
14 | Ludwig H, Van Belle S, Barrett-Lee P, et al (2004). The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer, 40, 2293-306. DOI ScienceOn |
15 | McMillan DC (2009). Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care, 12, 223-6. DOI ScienceOn |
16 | Nakahara Y, Mochiduki Y, Miyamoto Y, et al (2005). Prognostic significance of the lymphocyte-to-neutrophil ratio in percutaneous fine-needle aspiration biopsy specimens of advanced non-small cell lung carcinoma. Cancer, 104, 1271-80. DOI ScienceOn |
17 | Pircher A, Ulsperger E, Hack R, et al (2011). Basic clinical parameters predict gefitinib efficacy in non-small cell lung cancer. Anticancer Res, 31, 2949-55. |
18 | Rozhin J, Sameni M, Ziegler G, Sloane BF (1994). Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res, 54, 6517-25. |
19 | Sharma R, Zucknick M, London R, et al (2008). Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer. Clin Colorectal Cancer, 7, 331-7. DOI ScienceOn |
20 | Sarraf KM, Belcher E, Raevsky E, et al (2009). Neutrophil/ lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg, 137, 425-8. DOI ScienceOn |
21 | Tomita M, Shimizu T, Ayabe T, et al (2011). Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for non-small cell lung cancer. Anticancer Res, 31, 2995-8. |
22 | Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29. DOI ScienceOn |
23 | Smith RA, Ghaneh P, Sutton R, et al (2008). Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio. J Gastrointest Surg, 12, 1068-73. DOI |
24 | Teramukai S, Kitano T, Kishida Y, et al (2009). Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer, 45, 1950-8. DOI ScienceOn |
25 | Vaupel P, Thews O, Hoeckel M (2001). Treatment resistance of solid tumors: role of hypoxia and anemia. Med Oncol, 18, 243-59. DOI ScienceOn |
26 | Vlachostergios PJ, Gioulbasanis I, Kamposioras K, et al (2011). Baseline insulin-like growth factor-I plasma levels, systemic inflammation, weight loss and clinical outcome in metastatic non-small cell lung cancer patients. Oncology, 81, 113-8. DOI ScienceOn |
27 | Wang JY, Chen KY, Wang JT, et al (2002). Outcome and prognostic factors for patients with non-small-cell lung cancer and severe radiation pneumonitis. Int J Radiat Oncol Biol Phys, 54, 735-41. DOI ScienceOn |
28 | Yao Y, Yuan D, Liu H, et al (2013). Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy. Cancer Immunol Immunother, 62, 471-9. DOI ScienceOn |
29 | Zhang J, Huang SH, Li H, et al (2013). Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer. Med Oncol, 30, 352-3. DOI ScienceOn |